The same group demonstrated that miR-25-3p silences the Dickkopf WNT signaling pathway inhibitor 3 (DKK3) gene, thus supporting in vitro cancer growth and resistance to different chemotherapeutics [methotrexate, cisplatin, doxorubicin, and docetaxel (DOC)]. Here, DKK3 is linked to cancer.